Autonomize has filed a notice of an exempt offering of securities to raise $4,024,994.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Autonomize is raising $4,024,994.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Ganesh Padmanabhan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Autonomize
Autonomize is a human-centered AI company that automates insights from multi-structured clinical and biomedical data, to augment Healthcare organizations make critical decisions with speed and accuracy. We extract contextual information from multi-structured healthcare data, enrich with human know-how & aid decision making and data discovery. Extract multi-structured data like EMR, Labs, Imaging, Literature, Omics, and turn to structured form to compute and analyze. Enrich and link complex extracted information to 20+ industry-standard ontologies, including UMLS, SNOMED, ICD-10, RxNorm, MeSH etc, and capture human context to make data actionable. Augment decision making with breakthrough insights from highly contextualized, interconnected, analysis-ready data, with interactive visualizations and consumable APIs.
To learn more about Autonomize, visit http://www.autonomize.ai/
Contact:
Ganesh Padmanabhan, Chief Executive Officer
512-655-3708
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.